These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 437913)

  • 1. Induction of aryl hydrocarbon hydroxylase activity and pulmonary carcinoma.
    Gahmberg CG; Sekki A; Kosunen TU; Holsti LR; Mäkelä O
    Int J Cancer; 1979 Mar; 23(3):302-5. PubMed ID: 437913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questionable relation of aryl hydrocarbon hydroxylase to lung-cancer risk.
    Paigen B; Gurtoo HL; Minowada J; Houten L; Vincent R; Paigen K; Parker NB; Ward E; Hayner NT
    N Engl J Med; 1977 Aug; 297(7):346-50. PubMed ID: 876325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon hydroxylase inducibility and lymphoblast formation in lung cancer patients.
    Prasad R; Prasad N; Harrell JE; Thornby J; Liem JH; Hudgins PT; Tsuang J
    Int J Cancer; 1979 Mar; 23(3):316-20. PubMed ID: 437915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon hydroxylase activity in pulmonary macrophages and lymphocytes from lung cancer and noncancer patients.
    McLemore TL; Martin RR; Busbee DL; Richie RC; Springer RR; Toppell KL; Cantrell ET
    Cancer Res; 1977 Apr; 37(4):1175-81. PubMed ID: 844043
    [No Abstract]   [Full Text] [Related]  

  • 5. Aryl hydrocarbon hydroxylase in bronchogenic carcinoma.
    Lieberman J
    N Engl J Med; 1978 Mar; 298(12):686-7. PubMed ID: 628391
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of aryl hydrocarbon hydroxylase activity in human lung tissue, pulmonary macrophages, and blood lymphocytes.
    McLemore TL; Martin RR; Pickard LR; Springer RR; Wray NP; Toppell KL; Mattox KL; Guinn GA; Cantrell ET; Busbee DL
    Cancer; 1978 Jun; 41(6):2292-300. PubMed ID: 657093
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of cigarette smoke on aryl hydrocarbon hydroxylase activity and cytochrome P450 content in rat liver and lung microsomes.
    Kushinsky R; Louis CJ
    Oncology; 1976; 33(5-6):197-200. PubMed ID: 1026852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon hydroxylase induction levels in patients with malignant tumors associated with smoking.
    Korsgaard R; Trell E; Simonsson BG; Stiksa G; Janzon L; Hood B; Oldbring J
    J Cancer Res Clin Oncol; 1984; 108(3):286-9. PubMed ID: 6511802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon hydroxylase inducibility in lung cancer patients undergoing radiotherapy.
    Prasad N; Prasad R; Harrell JE; Thornby J; Liem JH; Hudgins PT; Guinn GA
    Int J Cancer; 1979 Oct; 24(4):415-20. PubMed ID: 528067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl-hydrocarbon-hydroxylase inducibility in patients with cancer.
    Emery AE; Anand R; Danford N; Duncan W; Paton L
    Lancet; 1978 Mar; 1(8062):470-2. PubMed ID: 76021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of benzopyrene-hydroxylase (cytochrome P-450) activity in patients with lung cancer].
    Ostashevskiĭ VA; Narov IuE
    Vopr Onkol; 1987; 33(11):62-5. PubMed ID: 3686924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of aryl hydrocarbon hydroxylase activity in cultured human lymphocytes.
    Suolinna EM; Vänttinen E; Aitio A
    Toxicology; 1982; 24(1):73-84. PubMed ID: 7135405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls.
    Kärki NT; Pokela R; Nuutinen L; Pelkonen O
    Int J Cancer; 1987 May; 39(5):565-70. PubMed ID: 3570549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls.
    Guirgis HA; Lynch HT; Mate T; Harris RE; Wells I; Caha L; Anderson J; Maloney K; Rankin L
    Oncology; 1976; 33(3):105-9. PubMed ID: 1012643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of aryl hydrocarbon hydroxylase inducibility in cultured human lymphocytes.
    Paigen B; Minowada J; Gurtoo HL; Paigen K; Parker NB; Ward E; Hayner NT; Bross ID; Bock F; Vincent R
    Cancer Res; 1977 Jun; 37(6):1829-37. PubMed ID: 870187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon hydroxylase activity in pulmonary alveolar macrophages and lymphocytes from lung cancer and noncancer patients: a correlation with family histories of cancer.
    McLemore TL; Martin RR; Springer RR; Wray N; Cantrell ET; Busbee DL
    Biochem Genet; 1979 Oct; 17(9-10):795-806. PubMed ID: 540021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic determination of aryl hydrocarbon hydroxylase activity and its significance in the etiology of lung cancer].
    Pawlak AL
    Pneumonol Pol; 1979; 47(7-8):565-72. PubMed ID: 575421
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of aryl hydrocarbon hydroxylase induction in cultured blood lymphocytes and pulmonary macrophages.
    McLemore TL; Martin RR; Toppell KL; Busbee DL; Cantrell ET
    J Clin Invest; 1977 Nov; 60(5):1017-24. PubMed ID: 908748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Methylcholanthrene inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes depends upon the extent of blast transformation.
    Hart P; Cooksley WG; Farrell GC; Powell LW
    Biochem Pharmacol; 1977 Oct; 26(19):1831-4. PubMed ID: 907723
    [No Abstract]   [Full Text] [Related]  

  • 20. Aryl hydrocarbon hydroxylase inducibility is not altered in bladder cancer patients or their progeny.
    Paigen B; Ward E; Steenland K; Havens M; Sartori P
    Int J Cancer; 1979 Mar; 23(3):312-5. PubMed ID: 437914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.